Pardes Biosciences
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2173 Salk Ave Ste 250, Carlsbad, Califor...Phone Number
(415) 649-8758Website
www.pardesbio.comRevenue
$7.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Pardes Biosciences
Founded in 2020, Pardes Biosciences is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease beginning with COVID-19. They are based in Carlsbad, California.Explore more
Pardes Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pardes Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Pardes Biosciences has new funding data
Product Launch: Get notified when Pardes Biosciences launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Pardes Biosciences recently announced quarterly report
Pardes Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Pardes Biosciences had a recent Job posting/layoffs
Check if Pardes Biosciences has recently received funding, and reach out quickly before it becomes old news!
Check out if Pardes Biosciences is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Pardes Biosciences
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Pardes Biosciences
Compare insights from companies similar to Pardes Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pardes Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pardes Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pardes Biosciences.
Pardes Biosciences Tech Stack
A closer look at the technologies used by Pardes Biosciences
Most Recent Scoops
Open Position
Open Position
Lateral Move
Executive Move
Board of Directors
New Hire
Executive Move
Board of Directors
Lateral Move
Executive Move
Board of Directors
Pardes Biosciences News & Media
MediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences Shares
LARKSPUR, Calif.--(BUSINESS WIRE)-- #lifesciences--As previously announced, on July 16, 2023, MediPacific Sub, Inc. (“Purchaser”) and MediPacific, Inc. (“Parent”), affiliates of Foresite Capital, entered into a definitive agreement and plan of merger (the “Merger Agreement”) with Pardes Biosciences, Inc. (Nasdaq: PRDS) (“Pardes”) whereby Purchaser agreed to acquire, subject to the terms of the Merger Agreement, Pardes for a price per share of not less than $2.02 in cash and an additional cash amSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Pardes Biosciences, Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - July 20, 2023) - Rigrodsky Law, P.A. is investigating Pardes Biosciences, Inc. ("Pardes") (NASDAQ: PRDS) regarding possible breaches of fiduciary duties and other violations of law related to Pardes' agreement to be acquired by MediPacific. Under the terms of the agreement, Pardes shareholders will receive no less than $2.02 per share in cash.To learn more about this investigation and your rights, visit:...INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Pardes Biosciences, Inc. and Encourages Investors with Losses to Contact the Firm
Los Angeles, California--(Newsfile Corp. - July 18, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Pardes Biosciences, Inc. ("Pardes" or "the Company") (NASDAQ: PRDS) for potential breaches of fiduciary duty on the part of its directors and management in connection with the Company's agreement to be acquired by MediPacific, Inc. ("MediPacific").The investigation focuses on determining if the Pardes..PRDS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Pardes Biosciences, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Pardes Biosciences, Inc. (NASDAQ: PRDS) to MediPacific, Inc. is fair to Pardes shareholders. Per the terms of the agreement, MediPacific would acquire all outstanding shares of Pardes for not less than $2.02 in cash and an additional cash amount of not more than $0.17 per share at closing, plus a non-tradeable contingent value right representing the right to receive
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pardes Biosciences
Sign Up For FreeTo access detailed company insights
Founded in 2020, Pardes Biosciences is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease beginning with COVID-19. They are based in Carlsbad, California.... Read More
